Reviews the mechanisms and clinical implications of drug resistance in cancer, considered to be the most significant obstacle to the cure of cancer today. Topics covered include multiple drug resistance and its reversal, topoisomerase drugs, apoptosis, dose intensity and escalation, gene therapy and haematopoietic support.
Reviews the mechanisms and clinical implications of drug resistance in cancer, considered to be the most significant obstacle to the cure of cancer today. Topics covered include multiple drug resistance and its reversal, topoisomerase drugs, apoptosis, dose intensity and escalation, gene therapy and haematopoietic support.Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
List of contributors Series editor's preface Abbreviations 1. Resistance mechanisms to antimetabolites Erdem Göker, Richard Gorlick and Joseph R. Bertino 2. Resistance to antitumor alkylating agents and cisplatin Beverly A. Teicher and Emil Frei III 3. The MDR genes Lyn Mickley and Antonio Tito Fojo 4. Topoisomerase genes and resistance to topoisomerase inhibitors Giuseppe Giaccone 5. Genes that modulate apoptosis: major determinants of drug resistance John A. Hickman 6. Clinical implications of drug resistance Henk M. W. Verheul and Herbert M. Pinedo 7. The reversal of multidrug resistance William S. Dalton 8. Effect of dose and schedule on chemotherapeutic drug resistance David Fennelly, George Raptis, John P. A. Crown and Larry Norton 9. Circumvention of drug resistance by high-dose chemotherapy in solid tumors Elisabeth G. E. de Vries, Wil Dolsma, Geke A. P. Hospers and Nanno H. Mulder 10. Enhancing drug effectiveness by gene transfer Karol Sikora Index.
List of contributors Series editor's preface Abbreviations 1. Resistance mechanisms to antimetabolites Erdem Göker, Richard Gorlick and Joseph R. Bertino 2. Resistance to antitumor alkylating agents and cisplatin Beverly A. Teicher and Emil Frei III 3. The MDR genes Lyn Mickley and Antonio Tito Fojo 4. Topoisomerase genes and resistance to topoisomerase inhibitors Giuseppe Giaccone 5. Genes that modulate apoptosis: major determinants of drug resistance John A. Hickman 6. Clinical implications of drug resistance Henk M. W. Verheul and Herbert M. Pinedo 7. The reversal of multidrug resistance William S. Dalton 8. Effect of dose and schedule on chemotherapeutic drug resistance David Fennelly, George Raptis, John P. A. Crown and Larry Norton 9. Circumvention of drug resistance by high-dose chemotherapy in solid tumors Elisabeth G. E. de Vries, Wil Dolsma, Geke A. P. Hospers and Nanno H. Mulder 10. Enhancing drug effectiveness by gene transfer Karol Sikora Index.
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Internetauftritt der buecher.de internetstores GmbH
Geschäftsführung: Monica Sawhney | Roland Kölbl | Günter Hilger
Sitz der Gesellschaft: Batheyer Straße 115 - 117, 58099 Hagen
Postanschrift: Bürgermeister-Wegele-Str. 12, 86167 Augsburg
Amtsgericht Hagen HRB 13257
Steuernummer: 321/5800/1497